BOSTON and SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused […]

The development of VTP-300 in chronic Hepatitis B (CHB) and VTP-1000 in celiac disease will be prioritized. The pipeline prioritization […]

– Oral difelikefalin did not demonstrate meaningful clinical benefit compared to placebo – – Company will discontinue clinical program in […]

Catcha Shareholders Approved the Previously Announced Business Combination at the Extraordinary General Meeting held June 12, 2024 Crown and Catcha […]

NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) — Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that […]

Agreement reached with FDA that cerebral spinal fluid (CSF) heparan sulfate (HS) can be used as a reasonable surrogate endpoint […]

RESEARCH TRIANGLE PARK, N.C., June 12, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today […]

WARREN, N.J., June 12, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage […]